CoChat

Remimazolam Attenuates LPS-Derived Cognitive Dysfunction via Subdiaphragmatic Vagus Nerve Target α7nAChR-Mediated Nrf2/HO-1 Signal Pathway

Open access
Zhou, Zhan, Yang, Ying, Wei, Yi, Xie, Yubo · 2024 · Neurochemical Research

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Sepsis-induced neuroinflammation is significantly associated with sepsis-related brain dysfunction. Remimazolam is a novel ultra-short-acting benzodiazepine anesthetic with multiple organ protective effects. However, it is unknown whether remimazolam can ameliorate LPS-induced brain impairment. In this study, Lipopolysaccharide (5 mg/kg, LPS) severely impaired Sprague-Dawley rats spatial learning ability, memory, and cognitive function. However, remimazolam treatment showed a protective effect on LPS-induced cognitive dysfunction. Remimazolam partly reversed LPS-induced splenomegaly, decreased serum cytokine expression, suppressed hippocampal M1 microglial activation, and mitigated oxidative stress injury and neuroinflammation. Electroacupuncture (EA) or PNU282987 treatment improved LPS-induced cognitive dysfunction and also significantly inhibited neuroinflammation and systemic inflammation. However, MLA, ML385, or subdiaphragmatic vagus nerve (SDV) treatment abolished the protective effects of remimazolam. Further mechanistic studies showed that remimazolam induces protective effects by activating subdiaphragmatic vagus nerve target α7nAChR-mediated Nrf2/HO-1 signaling pathway. These results demonstrate that remimazolam can up-regulate α7nAChR, Cyto-Nrf2, HO-1, and cognitive-related (CREB, BDNF, PSD95) protein expressions, suppress M1 microglia, ameliorate neuroinflammation or systemic inflammation, and reverse cognitive dysfunction. Therefore, this study provides insight into a new therapeutic target for the treatment of sepsis-induced cerebral dysfunction. Graphical Abstract

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11064-024-04115-x

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schematic flowchart of the experiment. The experiment was divided into three parts according to the experimental design. The first phase describes the brain-protective effect of remimazolam. Briefly, control and LPS groups were intraperitoneally (i.p) treated with saline or LPS (5 mg/kg). Remimazolam (10 mg/kg) or saline was intravenously injected 30 min after LPS injection. The second phase involved the investigation of the role of α7nAChR target and Nrf2/HO-1 signaling pathway in remimazolam treatment. Briefly, MLA (3 mg/kg), ML385 (30 mg/kg), or PNU282987 (10 mg/kg) were administered intraperitoneally 30 min before LPS infection. The third phase involved activation of the cholinergic pathway through surgery of SDV or sham rats two weeks before modeling. EA was also performed for five consecutive days. Created with BioRender.com
Fig. 1 Schematic flowchart of the experiment. The experiment was divided into three parts according to the experimental design. The first phase describes the brain-protective effect of remimazolam. Briefly, control and LPS groups were intraperitoneally (i.p) treated with saline or LPS (5 mg/kg). Remimazolam (10 mg/kg) or saline was intravenously injected 30 min after LPS injection. The second phase involved the investigation of the role of α7nAChR target and Nrf2/HO-1 signaling pathway in remimazolam treatment. Briefly, MLA (3 mg/kg), ML385 (30 mg/kg), or PNU282987 (10 mg/kg) were administered intraperitoneally 30 min before LPS infection. The third phase involved activation of the cholinergic pathway through surgery of SDV or sham rats two weeks before modeling. EA was also performed for five consecutive days. Created with BioRender.comCC BY · PubMed Central
Fig. 2 Remimazolam suppresses LPS-induced inflammation and M1 microglial activation a Representative images of the spleen. b Ratio of spleen weight/body weight. c TNF-α expression in hippocampus. d Serum TNF-α levels. e IL-6 expression in hippocampus. f Serum IL-6 levels. g SOD activity in hippocampus. h MDA content in hippocampus. i Immunofluorescence showing the activation of microglia in hippocampus (Red: Iba-1; Green: iNOS; Blue: DIPA; bar: 100 μm). j Iba-1 and iNOS expression levels. Data are expressed as mean ± SEM, n = 6/group
Fig. 2 Remimazolam suppresses LPS-induced inflammation and M1 microglial activation a Representative images of the spleen. b Ratio of spleen weight/body weight. c TNF-α expression in hippocampus. d Serum TNF-α levels. e IL-6 expression in hippocampus. f Serum IL-6 levels. g SOD activity in hippocampus. h MDA content in hippocampus. i Immunofluorescence showing the activation of microglia in hippocampus (Red: Iba-1; Green: iNOS; Blue: DIPA; bar: 100 μm). j Iba-1 and iNOS expression levels. Data are expressed as mean ± SEM, n = 6/groupCC BY · PubMed Central
Fig. 3 Remimazolam attenuates LPS-induced cognitive impairment a HE staining of hippocampus (×200). b Nissl-stained hippocampus. c The swim tracks of the rat during Morris water maze. d Escape latency to the platform during spatial working memory testing on days 1, 2, 3, 4 and 5. e Swimming speed during probe testing. f Platform-site crossings during probe testing. g The time traveled in the target quadrant during probe testing. h Representative images of hippocampus via Golgi staining (×200). i Representative images of dendrites in neurons of hippocampus (×1000) (The dendritic spine density = the number of spines /the length of dendrites* 10). Data are expressed as mean ± SEM, n = 6/group
Fig. 3 Remimazolam attenuates LPS-induced cognitive impairment a HE staining of hippocampus (×200). b Nissl-stained hippocampus. c The swim tracks of the rat during Morris water maze. d Escape latency to the platform during spatial working memory testing on days 1, 2, 3, 4 and 5. e Swimming speed during probe testing. f Platform-site crossings during probe testing. g The time traveled in the target quadrant during probe testing. h Representative images of hippocampus via Golgi staining (×200). i Representative images of dendrites in neurons of hippocampus (×1000) (The dendritic spine density = the number of spines /the length of dendrites* 10). Data are expressed as mean ± SEM, n = 6/groupCC BY · PubMed Central
Fig. 4 The roles of α7nAChR in remimazolam amelioration LPS-induced brain injury in rat a The predicted binding modes of remimazolam with α7nAChR. b, c Western blot analysis of α7nAChR in hippocampus. d Western blot analysis of Nuc-Nrf2 in hippocampus. e Western blot analysis of Cyto-Nrf2 in hippocampus. f Western blot analysis of HO-1 in hippocampus. g Western blot analysis of CREB in hippocampus. h Western blot analysis of BDNF in hippocampus. i Western blot analysis of PSD95 in hippocampus. Data are expressed as mean ± SEM, n = 6/group
Fig. 4 The roles of α7nAChR in remimazolam amelioration LPS-induced brain injury in rat a The predicted binding modes of remimazolam with α7nAChR. b, c Western blot analysis of α7nAChR in hippocampus. d Western blot analysis of Nuc-Nrf2 in hippocampus. e Western blot analysis of Cyto-Nrf2 in hippocampus. f Western blot analysis of HO-1 in hippocampus. g Western blot analysis of CREB in hippocampus. h Western blot analysis of BDNF in hippocampus. i Western blot analysis of PSD95 in hippocampus. Data are expressed as mean ± SEM, n = 6/groupCC BY · PubMed Central
Fig. 5 α7nAChR-mediated Nrf2/HO-1 signal activation exerts anti-inflammatory effects a TNF-α expression in hippocampus. b Serum TNF-α levels. c IL-6 expression in hippocampus. d Serum IL-6 levels. e SOD activity in hippocampus. f MDA content in hippocampus. g Immunofluorescence showing the activation of M1 microglia (Red: Iba-1; Green: iNOS; Blue: DIPA; bar: 100 μm). h Iba-1and iNOS expression levels. i Western blot analysis of Nuc-Nrf2 in hippocampus. j Western blot analysis of Cyto-Nrf2 in hippocampus k Western blot analysis of HO-1 in hippocampus. Data are expressed as mean ± SEM, n = 6 /group
Fig. 5 α7nAChR-mediated Nrf2/HO-1 signal activation exerts anti-inflammatory effects a TNF-α expression in hippocampus. b Serum TNF-α levels. c IL-6 expression in hippocampus. d Serum IL-6 levels. e SOD activity in hippocampus. f MDA content in hippocampus. g Immunofluorescence showing the activation of M1 microglia (Red: Iba-1; Green: iNOS; Blue: DIPA; bar: 100 μm). h Iba-1and iNOS expression levels. i Western blot analysis of Nuc-Nrf2 in hippocampus. j Western blot analysis of Cyto-Nrf2 in hippocampus k Western blot analysis of HO-1 in hippocampus. Data are expressed as mean ± SEM, n = 6 /groupCC BY · PubMed Central
Fig. 6 α7nAChR-mediated Nrf2/HO-1 signaling activation exerts the protective effects on cognitive function a The swim tracks of the rat during Morris water maze. b Escape latency to the platform during spatial working memory testing on days 1, 2, 3, 4 and 5. c Swimming speed during probe testing. d Platform-site crossings during probe testing. e The time traveled in the target quadrant during probe testing. f Western blot analysis of α7nAChR in hippocampus. g Western blot analysis of CREB in hippocampus. h Western blot analysis of BDNF in hippocampus. i Western blot analysis of PSD95 in hippocampus. Data are expressed as mean ± SEM, n = 6/group
Fig. 6 α7nAChR-mediated Nrf2/HO-1 signaling activation exerts the protective effects on cognitive function a The swim tracks of the rat during Morris water maze. b Escape latency to the platform during spatial working memory testing on days 1, 2, 3, 4 and 5. c Swimming speed during probe testing. d Platform-site crossings during probe testing. e The time traveled in the target quadrant during probe testing. f Western blot analysis of α7nAChR in hippocampus. g Western blot analysis of CREB in hippocampus. h Western blot analysis of BDNF in hippocampus. i Western blot analysis of PSD95 in hippocampus. Data are expressed as mean ± SEM, n = 6/groupCC BY · PubMed Central
Fig. 7 The roles of subdiaphragmatic vagus nerve integrity in the anti-inflammatory effects of remimazolam. a TNF-α expression in hippocampus. b Serum TNF-α levels c IL-6 expression in hippocampus. d Serum IL-6 levels. e SOD activity in hippocampus. f MDA content in hippocampus. g Immunofluorescence showing the activation of M1 microglia (Red: Iba-1; Green: iNOS; Blue: DIPA; bar: 100 μm). h Iba-1 and iNOS expression levels. i Western blot analysis of Nuc-Nrf2 in hippocampus. j Western blot analysis of Cyto-Nrf2 in hippocampus k Western blot analysis of HO-1 in hippocampus. Data are expressed as mean ± SEM, n = 6/group.
Fig. 7 The roles of subdiaphragmatic vagus nerve integrity in the anti-inflammatory effects of remimazolam. a TNF-α expression in hippocampus. b Serum TNF-α levels c IL-6 expression in hippocampus. d Serum IL-6 levels. e SOD activity in hippocampus. f MDA content in hippocampus. g Immunofluorescence showing the activation of M1 microglia (Red: Iba-1; Green: iNOS; Blue: DIPA; bar: 100 μm). h Iba-1 and iNOS expression levels. i Western blot analysis of Nuc-Nrf2 in hippocampus. j Western blot analysis of Cyto-Nrf2 in hippocampus k Western blot analysis of HO-1 in hippocampus. Data are expressed as mean ± SEM, n = 6/group.CC BY · PubMed Central
Fig. 8 The role of subdiaphragmatic vagus nerve integrity in remimazolam rescue of LPS-induced cognitive dysfunction. a The swim tracks of the rat during Morris water maze. b Escape latency to the platform during spatial working memory testing on days 1, 2, 3, 4 and 5. c Swimming speed during probe testing. d Platform-site crossings during probe testing. e The time traveled in the target quadrant during probe testing. f Western blot analysis of CREB in hippocampus. g Western blot analysis of BDNF in hippocampus. h Western blot analysis of PSD95 in hippocampus. Data are expressed as mean ± SEM, n = 6/group
Fig. 8 The role of subdiaphragmatic vagus nerve integrity in remimazolam rescue of LPS-induced cognitive dysfunction. a The swim tracks of the rat during Morris water maze. b Escape latency to the platform during spatial working memory testing on days 1, 2, 3, 4 and 5. c Swimming speed during probe testing. d Platform-site crossings during probe testing. e The time traveled in the target quadrant during probe testing. f Western blot analysis of CREB in hippocampus. g Western blot analysis of BDNF in hippocampus. h Western blot analysis of PSD95 in hippocampus. Data are expressed as mean ± SEM, n = 6/groupCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 37

Metadata

Authors
Zhou, Z., Yang, Y., Wei, Y., & Xie, Y.
Affiliations
  • First Affiliated Hospital of GuangXi Medical University (CN)
  • Guangxi Medical University (CN)
Corresponding author
Xie, Yubo
Venue
Neurochemical Research
Published
2024-03-12
Volume
49
Issue
5
Pages
1306-1321
ISSN
  • 0364-3190 (ISSN-L)
  • 1573-6903
OpenAlex
W4393953125
Cited by
30
References
37
Citations by year
2026: 12 · 2025: 17 · 2024: 1
FWCI
4.84
Type
journal article
Language
en
Open access
Licence
Locations
  • Neurochemical Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Special Fund of Neurotoxicity of General Anesthetics and Its Prevention and Treatment Innovation Team of the First Affiliated Hospital of Guangxi Medical University (No. YYZS2022001)
  • Guangxi Clinical Research Center for Anesthesiology (No. GK AD22035214)
  • the Key Project of Natural Science Foundation of Guangxi (No. 2020GXNSFDA238025)
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Anesthesia and Neurotoxicity Research
  • Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
remimazolam, lipopolysaccharide, cognitive impairment, alpha7 nicotinic acetylcholine receptor, Nrf2/HO-1 pathway, hippocampus, electroacupuncture, oxidative stress, systemic inflammation, brain-derived neurotrophic factor, CREB, PSD-95
MeSH terms
Neuroinflammatory Diseases, Animals, Benzodiazepines, Inflammation, Lipopolysaccharides, Vagus Nerve, Signal Transduction, Rats, Sprague-Dawley, Sepsis, NF-E2-Related Factor 2, Rats, Cognitive Dysfunction, alpha7 Nicotinic Acetylcholine Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Remimazolam Attenuates LPS-Derived Cognitive Dysfunction via Subdiaphragmatic Vagus Nerve Target α7nAChR-Mediated Nrf2/HO-1 Signal Pathway. https://app.cochat.ai/papers/10.1007/s11064-024-04115-x
The paper
Zhou, Z., Yang, Y., Wei, Y., & Xie, Y. (2024). Remimazolam Attenuates LPS-Derived Cognitive Dysfunction via Subdiaphragmatic Vagus Nerve Target α7nAChR-Mediated Nrf2/HO-1 Signal Pathway. Neurochemical Research. https://doi.org/10.1007/s11064-024-04115-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.